$CTIC News Insider filings one way to track tricky

New Post Public Reply Private Reply Replies (0) Message Board

Jan 4, 2015 at 10:06 AM

$CTIC News

Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com

Insider Trading Alert - CTIC, FXCM And CRM Traded By Insiders 10:45 a.m. Dec. 22, 2014 - TheStreet.com
2015 Biotech Drug/Stock Outlook: Here's What You Need to Know 9:20 a.m. Dec. 17, 2014 - TheStreet.com
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs 11:20 a.m. Dec. 16, 2014 - TheStreet.com
Insider Trading Alert - CSU, IRBT And CTIC Traded By Insiders 10:45 a.m. Dec. 8, 2014 - TheStreet.com
CTI BioPharma earns $15M milestone 7:46 a.m. Dec. 4, 2014 - Seeking Alpha
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off 11:00 a.m. Dec. 2, 2014 - TheStreet.com
Incyte Building Blockbuster Drug One Disease At A Time 2:58 p.m. Nov. 17, 2014 - Investors Business Daily
Insider Trading Alert - CTIC, SAM And DGI Traded By Insiders 11:00 a.m. Nov. 7, 2014 - TheStreet.com
10-Q: CTI BIOPHARMA CORP 5:12 a.m. Oct. 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
CTI BioPharma's (CTIC) CEO James Bianco on Q3 2014 Results - Earnings Call Transcript 2:10 a.m. Oct. 30, 2014 - Seeking Alpha
CTI BioPharma (CTIC) Q3 2014 Results - Earnings Call Webcast 3:25 p.m. Oct. 29, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up 9/24/14: Mercer International, OPKO Health, New Media, CTI BioPharma 7:17 a.m. Sept. 25, 2014 - Seeking Alpha
Merrimack Does Well to License Marginal Cancer Drug to Baxter 7:14 a.m. Sept. 24, 2014 - TheStreet.com
CTI BioPharma and Servier collaborate on cancer drug 7:19 a.m. Sept. 17, 2014 - Seeking Alpha
SEC Slaps Biotech Hedge Fund for Short-Selling Violations 12:04 p.m. Sept. 16, 2014 - TheStreet.com
CTI BioPharma set for gap up at the open 7:00 a.m. Sept. 9, 2014 - Seeking Alpha
Insider Trading Alert - MTDR, ABCO And CTIC Traded By Insiders 9:15 a.m. Aug. 18, 2014 - TheStreet.com
Insider Trading Alert - CMS, CTIC And WFT Traded By Insiders 9:15 a.m. Aug. 7, 2014 - TheStreet.com
CTI BioPharma's (CTIC) CEO Jim Bianco on Q2 2014 Results - Earnings Call Transcript 9:56 p.m. Aug. 4, 2014 - Seeking Alpha
10-Q: CTI BIOPHARMA CORP 4:07 p.m. Aug. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)

CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells 1:30 a.m. Dec. 9, 2014 - PR Newswire - PRF
CTI BioPharma Announces Comprehensive Kinome Analysis that Demonstrates Pacritinib Inhibits Kinases Linked to a Spectrum of Blood-Related Cancers 12:00 p.m. Dec. 6, 2014 - PR Newswire - PRF
CTI BioPharma Receives $15 Million Milestone Payment for TRISENOX® 1:30 a.m. Dec. 4, 2014 - PR Newswire - PRF
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
CTI BioPharma Announces Data Presentations at the 56th American Society of Hematology Annual Meeting 1:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
CTI BioPharma to Present at the Upcoming Investor Conferences 1:30 a.m. Nov. 17, 2014 - PR Newswire - PRF
CTI BioPharma Prices Underwritten Public Offering of $35 Million of Convertible Preferred Stock 9:15 a.m. Nov. 7, 2014 - PR Newswire - PRF
CTI BioPharma Announces Proposed Public Offering of Convertible Preferred Stock 4:15 p.m. Nov. 6, 2014 - PR Newswire - PRF
CTI BioPharma Reports Third Quarter 2014 Financial Results 3:01 p.m. Oct. 29, 2014 - PR Newswire - PRF
CTI Acquires Exclusive Worldwide License to Tosedostat, a Selective Oral Anti-Cancer Therapy 1:30 a.m. Oct. 27, 2014 - PR Newswire - PRF
CTI BioPharma to Report Third Quarter 2014 Financial Results on October 29, 2014 12:30 a.m. Oct. 20, 2014 - PR Newswire - PRF
Technical Updates on Health Care Sector Stocks - AstraZeneca, Novartis, Salix Pharma, Inovio Pharma, and CTI BioPharma 8:15 a.m. Oct. 6, 2014 - PR Newswire - PRF
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI® 12:30 a.m. Sept. 17, 2014 - PR Newswire - PRF
Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma 7:50 a.m. Aug. 25, 2014 - PR Newswire - PRF
FDA Grants Fast Track Designation to CTI BioPharma's Pacritinib, a Novel JAK2 Inhibitor for the Treatment of Myelofibrosis 12:30 a.m. Aug. 7, 2014 - PR Newswire - PRF
CTI BioPharma Reports Second Quarter 2014 Financial Results 3:01 p.m. Aug. 4, 2014 - PR Newswire - PRF
The Federal Reserve Playing Analyst Damaging to Biotechnology Companies 9:06 a.m. July 30, 2014 - ACCESSWIRE
CTI BioPharma to Report Second Quarter 2014 Financial Results on August 4, 2014 12:30 a.m. July 28, 2014 - PR Newswire - PRF
CTI BioPharma Expands Access To PIXUVRI® With Approval In Israel And Add-on Reimbursement Status In The Netherlands 12:30 a.m. July 21, 2014 - PR Newswire - PRF
Acquisitions, Study Results, Merger Agreements, and Completed Trial Recruitments - Analyst Notes on Cooper, Agenus, Transcept, CTI and ANI 5:00 a.m. July 4, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CourseArc Partners with Colleges for ADA Compliance

CourseArc's Landmark Deal with Public Colleges Well, slap me silly and call me a believer—looks like CourseArc just locked down a heck of a gig with a public college system that's head-over-heels squirming to meet shiny new accessibility demands. Nearly 200,000 learners are waiting at their gates, and this agreement is the lifeline for colleges to not only stay afloat...

AI Agents Race: 10M Downloads Spark Competitive Fire

The AI Agent Arms Race is On Throwdown time in the AI jungle, folks. A new AI agent hit the big 10.9 million downloads in a mere six weeks. In the digital world, those kinds of numbers are the equivalent of finding a unicorn in your backyard. This data gem comes courtesy of Sensor Tower, as reported by Yahoo Finance, and it looks like the appetite for this technological...

Anita Eno: 2027's Top Trailblazing Businesswoman

Anita Eno's Well-Deserved Recognition You've got to respect a story where someone claws their way up from humble beginnings to a position of serious influence. Anita Eno, Founder and CEO of Prayers Are Answered Inc., is one of those impressive figures, recently bagging the 2027 American Business Woman of the Year title. This accolade, dished out by the American Business...

York Space Systems Faces Securities Law Class Action

Unexpected Turbulence at York Space Systems Just when you thought things might be smooth sailing, York Space Systems (NYSE: YSS) finds itself on the hot seat. This fledgling aerospace player is now wrangling with a class action lawsuit for allegedly breaking federal securities laws. Call it a wake-up call from DJS Law Group encouraging investors who've had their fingers...

Rublev's Tennis Meet Boosts Inclusivity for Autism

Tennis Bridging Worlds in the Heart of Kazakhstan When Andrey Rublev, a powerhouse in the world of tennis, wields his racket for more than just a win, you know something special is brewing. During the Almaty Open ATP 250 tournament, he did exactly that, sharing the court not with rivals, but with ten spirited children from the Asyl Miras Autism Center. This heartwarming...

AMTD IDEA Group: Expanding Its Global Reach

AMTD IDEA's Expansive Global Footprint While the rest of the market whirls, AMTD IDEA Group (NYSE: AMTD) is steadying itself with a comprehensive expansion that, quite frankly, demands a second look. Between weaving global media threads and dipping their toes into every alluring venture space, they've formed a tapestry not many could replicate. With facilities stretching...

Shadeform Debuts Flex VMs, Revolutionizing GPU Utilization

GPU Utilization Gets a New Spin with Flex VMs Folks, listen up: Shadeform just fired up something slick with its new Flex VMs. And, let me tell you, in today's market where GPU capacity is vanishing faster than free hotcakes on a Sunday morning, this might well be a game changer. Shadeform’s the name to remember, teaming up data center veterans with peeps who need to...

Scrutinizing M&A Deals: VREX, HZO, SYNA Under Fire?

Alignment or Deception: The M&A Alarm Bells Investors, strap in, because the world of mergers and acquisitions is lighting up like a pinball machine, and today's spotlight's on Varex Imaging Corporation (NASDAQ: VREX), MarineMax (NYSE: HZO), and Synaptics Incorporated (NASDAQ: SYNA). Halper Sadeh LLC, known for their tenacity in championing shareholder rights, has brought...

SKF Q3 2026: Margins Edge Up Amid Strategic Shifts

Cracking Open SKF's Latest Quarterly Numbers Ever seen a company limber up for a big change while tiptoeing through a minefield? That’s SKF for you in this third quarter ending September 2026. Imagine them trying to juggle a spinning platter of growth, strategic separation, and robust margins, all while balancing a wobbly market. A Close Look at Q3's Financial Feats...

University of Phoenix Lowers Costs for Transfer Students

The Pocket-Saving Game of Transfer Credits Here's the buzz: the University of Phoenix is putting some serious coin back into students' pockets through transfer credits. We're looking at more than $12,010 in savings per student, thanks to these policies, which is no chump change by any stretch. As over 900,000 credits were tossed into the pot, the savings side of education...